HIGHLIGHTS
- who: Gianluca Mauri from the (UNIVERSITY) have published the Article: Multimodal treatment with curative intent in a germline, in the Journal: (JOURNAL)
- what: The authors report a clinical case of a platinum-sensitive metastatic AC patient in which the identification of a BRCA2 germline mutation drove a personalized multimodal approach with potential curative-intent.
SUMMARY
TP53 mutations (41-53%) and KRAS mutations (40%) are among the most common alterations found in ACs, while ERBB2/3 alterations and microsatellite instability (MSI) are rarer but may represent potential therapeutic targets in the metastatic . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.